Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation

Mathieu Kerneis,Megan K. Yee,Roxana Mehran,Tarek Nafee,Christoph Bode,Jonathan L. Halperin,Eric D. Peterson,Freek W.A. Verheugt,Peter Wildgoose,Martin van Eickels,Gregory Y.H. Lip,Marc Cohen,Keith A.A. Fox,C. Michael Gibson

Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial Fibrillation

2019

Mathieu Kerneis
Megan K. Yee
Roxana Mehran
Tarek Nafee
Christoph Bode
Jonathan L. Halperin
Eric D. Peterson
Freek W.A. Verheugt
Peter Wildgoose
Martin van Eickels
Gregory Y.H. Lip
Marc Cohen
Keith A.A. Fox
C. Michael Gibson

Background: Among stented patients with atrial fibrillation, double therapy with a novel oral anticoagulant plus single antiplatelet therapy (SAPT) reduces bleeding or cardiovascular rehospitalizat...

Keywords:

Atrial fibrillation
Cardiology
Medicine
Rivaroxaban
Internal medicine
Anticoagulant
Warfarin
Percutaneous coronary intervention
Vitamin K antagonist

Correction
Cite
Save
Machine Reading By IdeaReader

References

Citations